Compositions for medicinal Chemistry of fullerenes
The paper presents a quantum-chemical approach to two aspects of fullerene nanomedicine related to the oxidative and antioxidant actions of fullerene. The first topic is concerned in regards photodynamic therapeutic effect of fullerene solutions. A new mechanism of the effect is proposed. The second...
Gespeichert in:
Datum: | 2010 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Інститут хімії поверхні ім. О.О. Чуйка НАН України
2010
|
Schriftenreihe: | Хімія, фізика та технологія поверхні |
Online Zugang: | http://dspace.nbuv.gov.ua/handle/123456789/29021 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Zitieren: | Compositions for medicinal Chemistry of fullerenes / E.F. Sheka // Хімія, фізика та технологія поверхні. — 2010. — Т. 1, № 4. — С. 377-388. — Бібліогр.: 51 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-29021 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-290212011-11-29T12:05:57Z Compositions for medicinal Chemistry of fullerenes Sheka, E.F. The paper presents a quantum-chemical approach to two aspects of fullerene nanomedicine related to the oxidative and antioxidant actions of fullerene. The first topic is concerned in regards photodynamic therapeutic effect of fullerene solutions. A new mechanism of the effect is proposed. The second aspect is exemplified by the consideration of two fullerene-silica complexes, namely, fullerosil and fullerosilica gel. Стаття присвячена квантово-хімічному розгляду двох аспектів наномедицини фулерену, які стосуються його оксидативної та антиоксидативної функцій. Перший аспект розглянуто по відношенню до фотодинамічного терапевтичного ефекту розчинів фулерену. Запропоновано новий механізм цього ефекту. Другий аспект обговорюється на прикладі двох комплексів фулерену з кремнеземом: фулеросилу та фулеросилікагелю. Статья посвящена квантово-химическому рассмотрению двух аспектов наномедицины фуллерена, относящихся к его оксидативной и антиоксидантной функциям. Первый аспект рассмотрен применительно к фотодинамическому терапевтическому эффекту растворов фуллерена. Предложен новый механизм этого эффекта. Второй аспект обсуждается на примере двух комплексов фуллерена с кремнеземом: фуллеросила и фуллеросиликагеля. 2010 Article Compositions for medicinal Chemistry of fullerenes / E.F. Sheka // Хімія, фізика та технологія поверхні. — 2010. — Т. 1, № 4. — С. 377-388. — Бібліогр.: 51 назв. — англ. 2079-1704 http://dspace.nbuv.gov.ua/handle/123456789/29021 544.77.05+546.26+544.353.3 en Хімія, фізика та технологія поверхні Інститут хімії поверхні ім. О.О. Чуйка НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
description |
The paper presents a quantum-chemical approach to two aspects of fullerene nanomedicine related to the oxidative and antioxidant actions of fullerene. The first topic is concerned in regards photodynamic therapeutic effect of fullerene solutions. A new mechanism of the effect is proposed. The second aspect is exemplified by the consideration of two fullerene-silica complexes, namely, fullerosil and fullerosilica gel. |
format |
Article |
author |
Sheka, E.F. |
spellingShingle |
Sheka, E.F. Compositions for medicinal Chemistry of fullerenes Хімія, фізика та технологія поверхні |
author_facet |
Sheka, E.F. |
author_sort |
Sheka, E.F. |
title |
Compositions for medicinal Chemistry of fullerenes |
title_short |
Compositions for medicinal Chemistry of fullerenes |
title_full |
Compositions for medicinal Chemistry of fullerenes |
title_fullStr |
Compositions for medicinal Chemistry of fullerenes |
title_full_unstemmed |
Compositions for medicinal Chemistry of fullerenes |
title_sort |
compositions for medicinal chemistry of fullerenes |
publisher |
Інститут хімії поверхні ім. О.О. Чуйка НАН України |
publishDate |
2010 |
url |
http://dspace.nbuv.gov.ua/handle/123456789/29021 |
citation_txt |
Compositions for medicinal Chemistry of fullerenes / E.F. Sheka // Хімія, фізика та технологія поверхні. — 2010. — Т. 1, № 4. — С. 377-388. — Бібліогр.: 51 назв. — англ. |
series |
Хімія, фізика та технологія поверхні |
work_keys_str_mv |
AT shekaef compositionsformedicinalchemistryoffullerenes |
first_indexed |
2025-07-03T09:12:20Z |
last_indexed |
2025-07-03T09:12:20Z |
_version_ |
1836616453546049536 |
fulltext |
Хімія, фізика та технологія поверхні. 2010. Т. 1. № 4. С. 377–388
_____________________________________________________________________________________________
ХФТП 2010. Т. 1. № 4 377
UDC 544.77.05+546.26+544.353.3
COMPOSITIONS FOR MEDICINAL CHEMISTRY
OF FULLERENES
E.F. Sheka
Peoples` Friendship University of the Russian Federation
6 Miklukho-Maklay Street, Moscow 117198, Russia, sheka@icp.ac.ru
The paper presents a quantum-chemical approach to two aspects of fullerene nanomedicine
related to the oxidative and antioxidant actions of fullerene. The first topic is concerned in
regards photodynamic therapeutic effect of fullerene solutions. A new mechanism of the effect
is proposed. The second aspect is exemplified by the consideration of two fullerene-silica
complexes, namely, fullerosil and fullerosilica gel.
Статья посвящается памяти талантливого ученого,
креативного лидера и большого человека,
любившего науку и считавшего ее делом своей жизни,
умевшего одинаково искренне радоваться своим и чужим успехам,
Алексея Алексеевича Чуйко.
Автору дороги все встречи и беседы с этим неординарным человеком,
стимулировавшие, в частности, и это исследование.
INTRODUCTION
Nanomedicine of fullerene seems to be a
beautiful platform to illustrate the synergetic of
chemistry, biology and physics in fullerene sci-
ence. The modern medicinal fullerenics is a
largely explored field, actively developing and
enlarging. We are not going to go into the depth of
the topic and address readers to some exhausted
reviews just recently appeared [1–3]. Our purpose
is to show the basic grounds that lay the founda-
tion of biological and medicinal applications of
fullerenes to be tightly connected with distin-
guished properties of fullerenes. This concerns first
of all the mechanism of their therapeutic action.
For today a large number of efficient bio-
medical actions of fullerenes have been found
among which there are antiviral, anticancer, neu-
roprotective, enzymatic, antiapoptopic and many
others [4–6]. The list is worthwhile to supplement
by the latest sensational news on a fullerene-
based gene delivery in mice [7]. Expert judg-
ments suggest that this work opens a large way to
test efficacy of fullerenes for in vivo applications
such as insulin gene delivery to reduce blood glu-
cose levels for diabetes treatment and so forth.
Empirically estimated, fullerenes fulfill
therapeutic functions acting as either antioxidant
or oxidative agent thus revealing seemingly two
contradictory behaviors. However, this two-mode
behavior is just the manifestation of two appear-
ances of fullerenes that are, on one hand, radicals
due to the availability of a considerable number
of effectively unpaired electrons ND and an effi-
cient donor-acceptor (D-A) agent, on the other.
Actually, the consideration of chemical behavior
of fullerenes discussed in [8] clearly show that
they must willingly interact with other radicals
forming tightly bound compositions thus provid-
ing an efficient radical scavenging. In full consis-
tence with this statement, the first exhibited
therapeutic function of fullerene C60 was its ac-
tion as a radical scavenger [9]. Later on this laid
the foundation of the antioxidant administrating
of fullerenes in medical practice [10–12]. Estab-
lishing the preservation of antioxidant properties
in C60 derivatives in general as well as its de-
pendence on the chemical structure and, mainly,
on the number of attached chemical groups with a
clear preference towards monoderivatives, are in
a complete accordance with expected behavior of
molecular chemical susceptibility and can be
quantitatively described in terms of ND. It is
enough to remain a clearly justified working out
this pull of effectively unpaired electrons under
successive fluorination [13] and hydrogenation
E.F. Sheka
_____________________________________________________________________________________________
378 ХФТП 2010. Т. 1. № 4
[14]. Therefore, the antioxidant therapeutic func-
tion of fullerenes is intimately connected with
electronic structure of the molecule itself.
Oppositely to individual-molecule character
of the antioxidant action, the oxidative action of
fullerenes occurs under photoexcitation of their
solutions in both molecular and polar solvents in
the presence of molecular oxygen. The action
consists mainly in the oxidation of targets by
singlet oxygen 2
1O produced in due course of
photoexcitation of fullerene solutions. The differ-
ence in the behavior of singlet and triplet oxygen
is obviously connected with the difference in the
pairing of the molecule electrons caused by dif-
ferent spin multiplicity. A quantitative character-
istic of the pairing can be expressed in terms of
the total number of unpaired electrons ND. Calcu-
lations performed within the framework of the
UBS HF approach [15] expose ND =
2 for both
spin states. But, if for the triplet state this finding
just naturally reflects two electrons that are re-
sponsible for maintaining the molecule spin mul-
tiplicity, in the singlet state the availability of two
effectively unpaired electrons evidences a biradi-
cal character of the molecule which explains
2
1O
high oxidative activity. Therefore, the photo-
stimulated
2
1
2
3 OO → transformation in the pres-
ence of fullerene molecule just means exempting
the molecule two electrons from the spin multi-
plicity service thus transforming chemically inac-
tive molecule into a biradical.
The presence of fullerene for the photostimu-
lated
2
1
2
3 OO → transformation is absolutely manda-
tory, so that the treatment was called as photody-
namic fullerene therapy [16, 17]. For the reason
alone that the action is provided by a complex in-
volving fullerene and solvent molecules as well as
molecular oxygen, it becomes clear that it is re-
sulted from a particular intermolecular interaction.
However, until now, the mechanism of the photo-
dynamic therapy has been hidden behind a slogan
"triplet state photochemical mechanism" that implies
the excitation transfer over a chain of molecules
according to a widely accepted scheme [16–18]
60
1
60
3
60
1
60
1 2
1
2
3
CCCC OO →→→ →∗∗νh
.
Scheme 1
The scheme implies the energy transfer from
the singlet photoexcited fullerene to the triplet
one that further transfers the energy to convenient
triplet oxygen thus transforming the latter into
singlet oxygen. The first two stages of this "sin-
gle-fullerene-molecule" mechanism are quite evi-
dent while the third one, the most important for
the final output, is quite obscure in spite of a lot
of speculations available [18]. Obviously, the
stage efficacy depends on the strength of the in-
termolecular interaction between fullerene and
oxygen molecules. Numerous quantum chemical
calculations show that pairwise interaction in the
C60–O2 dyad in both singlet and triplet state is
practically absent. The AM1 UBS HF computa-
tions [15] fully support the previous data disclos-
ing the coupling energy of the dyad of
cplE − equal to
zero in both cases. This puts a serious problem
for the explanation of the third stage of the above
scheme forcing to suggest the origination of a
peculiar intermolecular interaction between C60
and O2 molecules in the excited state, once absent
in the ground state.
However, exclusive D-A ability of fullerenes
strongly influences intermolecular interaction
(IMI) [8] and cannot be omitted when considering
intermolecular events, particularly under photo-
excitation. Let us look at oxidative fullerene-
based solutions from this viewpoint.
SPIN-FLIP IN THE OXYGEN MOLECULE
IN FULLERENE SOLUTIONS
The system under consideration consists of
fullerene C60, solvent, both polar (water, etc.) and
nonpolar (benzene, etc.), and oxygen. Molecules
of fullerene and solvent are in singlet ground state
while the ground state of oxygen molecule is trip-
let. Let us call this system as photodynamic (PD)
solutions. There are a few types of IMI in the so-
lutions, among which we will be interested in the
IMI between fullerene molecules (f–f), between
fullerene and solvent molecules (f–s) and between
fullerene and oxygen (f–o). So far, we have
pointed aside the f–s IMI which might be impor-
tant in some cases (see the influence of this inter-
action on nanophotonics of fullerene solutions in
[8]). In the case of such solvents as benzene and
water it is very weak and can be neglected.
In contrast, interaction between fullerene
molecules is rather significant and causes the
fullerene clusterization that is experimentally
proven in many cases (see for example [19–22]).
Consequently, instead of an ideal solution, the PD
one presents a conglomerate of clusterized C60
molecules as shown schematically in Fig. 1.
Compositions for Medicinal Chemistry of Fullerenes
_____________________________________________________________________________________________
ХФТП 2010. Т. 1. № 4 379
Fig. 1. Schematic presentation of an ideal (a) and real
(b) fullerene solution in the presence of molecu-
lar oxygen
As shown in [8], clusters of any composition
of C60 molecules have properties of charge trans-
fer complexes. Excitation by the UV visible light
of any of them provides the formation of a pair of
molecular ions that quickly relax into the ground
state of neutral molecule after the light is switched
off. In contrast to neutral C60, both molecular ions
C60
- and C60
+ efficiently interact with oxygen
molecule giving coupling energy cplE of -10.03
and -10.05 kcal/mol, respectively, referring to
2
3O molecule and -0.097 and -0.115 kcal/mol in
regards to
2
1O . Therefore, oxygen molecule is
quite strongly held in the vicinity of both molecu-
lar ions forming [ ]−+ 260 OС and [ ]++ 260 OС com-
plexes as schematically shown in Fig. 2.
-+
νh
Fig. 2. The formation of [ ]260
2
OС +− and [ ]260
2
OС ++
complexes under photoexcitation of (C60)5
cluster
UBS HF AM1 calculations for the corre-
sponding pairs show [15] that the complexes are
of [ ]260
2
OС +−
and [ ]260
2
OС ++ compositions of the
doublet spin multiplicity. Since both fullerene
ions take the responsibility over the complex spin
state, so that two electrons of the oxygen mole-
cule that were on the service of triplet spin multi-
plicity of [ ]260
3 )( OС n + dyads in the ground state
are not more needed for the job and become ef-
fectively unpaired thus adding two electrons to
the ND pool of unpaired electrons of complexes
[ ]260
2
OС +− and [ ]260
2
OС ++ . The distribution of effec-
tively unpaired electrons of both complexes over
their atoms, which displays the distribution of the
atomic chemical susceptibility of the complexes,
is shown in Fig. 3. A dominant contribution of
electrons located on oxygen atoms 61 and 62 is
clearly seen thus revealing the most active sites of
the complexes. It should be noted that these dis-
tributions are intimate characteristics of both
complexes so that not oxygen itself but both
complexes as a whole provide the oxidative ef-
fect. The effect is lasted until the complexes exist
and is practically immediately terminated if the
latter disappear when the light is switched off.
0
0.2
0.4
0.6
0.8
1
1.2
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 5557 59 61
Atom number
A
to
m
ic
c
h
em
ic
al
s
u
sc
e
pt
ib
ili
ty
N
D
A
,
e
Fig. 3. Distribution of atomic chemical susceptibility
NDA over atoms of [ ]260
2
OС +− (black bars)
and [ ]260
2
OС ++ (light gray bars) complexes
[15]. Curve with black dots plots distribution
over atoms of C60. UBS HF AM1 doublet and
singlet states
The obtained results make it possible to sug-
gest the following mechanism that lays the foun-
dation of the photodynamic effect of fullerene
solutions schematically presented as
[ ]260
3
)( OC n +
( )[ ]260260
2
OСC n +−
−
( )[ ]260260
2
OСС n ++
−νh
.
Scheme 2
Here ( ) +
− 60260 CС n and ( ) −
− 60260 CС n present
fullerene clusters incorporating molecular ions.
The transformation of the triplet ground state
complex into two doublet ones under
photoexcitation is accompanied with a spin flip of
the oxygen molecule electrons in the presence of
fullerene molecule which is shown scematically in
Fig. 4. This approach allows attributing photody-
namical effect of fullerene solutions to a new type
of chemical reactions in the modern spin chemistry.
E.F. Sheka
_____________________________________________________________________________________________
380 ХФТП 2010. Т. 1. № 4
+
+
νh+
+
-
Fig. 4. Schematic presentation of the spin-flip in oxy-
gen molecule under photoexcitation
Since fullerene derivatives preserve D-A
properties of pristine fullerene, Scheme 2 is fully
applied in this case as well. So that not only C60
or C70 themselves but their derivatives can be
used in PD solutions. However, parameters of the
photodynamic therapy occur therewith to be dif-
ferent depending on the fullerene derivative struc-
ture [23]. Changing solute molecules it is possible
to influence the efficacy of their clusterization
that, in its turn, may either enhance or press the
therapeutic effect [2, 18]. The situation appears to
be similar to that occurred in nanophotonics of
fullerene solution. In more details this similarity
is discussed in [8].
FULLERENE–SILICA COMPLEXES
FOR MEDICINAL CHEMISTRY
If photodynamical therapy is mainly adminis-
tered by using aqueous solution, the delivery of
fullerene-based antioxidant in a living body pre-
sents a serious problem. A few types of tech-
niques have been suggested for medical practice
until now among them there are the following
mostly used [2]:
1. films or fullerene-coated surfaces containing
immobilized fullerene [24]
2. aqueous suspensions of micronized crystal-
line fullerene [25, 26]
3. stable colloidal fullerene solutions in water [27]
4. water soluble fullerene-based complexes [28]
5. water soluble fullerene derivatives [29].
Each of these techniques covers a large field
of investigations and has own advantages and
disadvantages. The author previous experience in
amorphous silica study [30], complemented by
knowledge about high medicinal activity of
nanosize silica (NSS) [31], forced to think about a
possibility of conjugation of silica and fullerene
to provide an easy delivery of the medicament in
the body just using NSS as a carrier of immobi-
lized fullerene molecules as well as about
strengthening therapeutic effects of each compo-
nents in a synergetic manner [32].
As known, there are a few technological
polymorphs of NSS [30, 33], among which the
most popular are pyrogenic nanosized silica
(PNSS, or Aerosil), silica gel (SCG), and aerogel.
Either component of a possible NSS–C60 complex
exhibits an appreciable medico-biological effect;
for example, SCG-based enterosorbents are
widely used in medicine. More versatile, the me-
dicinal chemistry of PNSS has made even more
impressive progress [31]. One result of these stud-
ies is SILICS [34], a wide-spectrum-effect drug,
which proved to be not only a highly efficient en-
terosorbent, superior to all known sorbents, but
also an effective medicinal agent for monotherapy
of various diseases [31]. The biomedical activity of
fullerenes has been discussed earlier. The main
factors that make them biologically active are
summarized in Table. In this connection, it is
seems natural to find out what effect these two
component would produce when combined.
Table 1. Main factors underlying the biomedical activ-
ity of pyrogenic nanosized silica (PNSS) and
C60 fullerene
SILICS [34] C60 fullerene [2]
high hydrophobicity of the
PNSS surface
antioxidant activity
high efficiency in the sorp-
tion of proteins
neuroprotective activity
agglutination of a large
number of microorganisms
and microbial toxins
antivirus and
antimicrobial effect
adsorption of low-
molecular-weight com-
pounds
inhibition of enzymatic
activity
enhancement of the action
of immunoactive drugs
gene delivery
inhibition of the aggrega-
tion of thrombocyte, etc.
The idea of creating complex drugs on the
basis of NSS is not new. For example, experi-
ments with PNSS covered with various medicinal
agents, such as amphotericin and highly dispersed
medicinal plants, demonstrated [35] that the use
of such composite systems with a prolonged ac-
tion of the drug may decrease its dose and en-
hance its bioaccessibility, features indicative of a
synergistic action of the ingredients. Moreover,
composite system on the basis of fullerene and
highly dispersed silica were also used [36–39].
The carrier was a highly porous SCG. It was
Compositions for Medicinal Chemistry of Fullerenes
_____________________________________________________________________________________________
ХФТП 2010. Т. 1. № 4 381
demonstrated that appreciable amounts of
fullerene are adsorbed and/or retained in the SCG
pores. Fullerene–SCG composites (fullerenized
SCG, in the terminology of [36]) selectively ad-
sorb low-density lipoproteins (LDLP), a property
that makes them effective immunosorbents for
treating atherosclerosis. But it remains unknown
how C60 fullerene is bound to the carrier and how
its properties change because of this binding.
Empirically is known that C60 is a poor ad-
sorbate in regards to NSS substrates. Thus, the
specific amount of C60 fullerene (a hydrophobic
substance) adsorbed on unmodified PNSS, a hy-
drophilic carrier, proved extremely low. When
the surface of PNSS was modified, for example,
with amines, the amount of fullerene adsorbed
increased substantially [40]. The specific amount
of fullerene on aerogel was also very low [41].
And only SCG, according to [36–39] investiga-
tions, seemed to be promising. Let us look what is
going on the PNSS surface or inside SCG pore in
the presence of fullerene C60.
C60 FULLERENE–HIGHLY DISPERSED
SILICA COMPOSITE
NSSs are formed during the condensation or
polymerization that accompanies the hydrolysis
of silicon tetrahalides, their organic orthoesters,
and silicic acid salts [33]. The commercial prod-
ucts manufactured in these ways are known as
Aerosil, aerogel, and SCG. A special series of
experiments aimed at examining the vibrational
spectra of these products (summarized in the re-
view [30]) showed that the spectra of the frame-
works and surface zones of these three types of
silicas differ so radically that they should be con-
sidered as different structural formations. The
finding has led to exhibiting new structural phe-
nomenon called technological polymorphism of
NSS. A comprehensive understanding of the mo-
tivation leading to the formation of different
polymorphs gave rise to a new algorithmic ap-
proach to modeling NSSs [30]. Let us briefly
consider the main point of the approach.
Aerosil (PNSS). Aerosil is prepared by the
hydrolysis of silicon tetrachloride in an oxygen–
hydrogen flame with the subsequent polyconden-
sation of orthosilic acid formed at the first stage.
Agglomerated solid-phase nuclei look like virtu-
ally ideal particles. The particles are composed of
closely packed silicon-oxygen tetrahedra (SOT)
with Si–O lengths lying in a narrow interval
(Fig. 5a). That the frequencies of bending (Si–O–Si
and O–Si–O) and torsional vibrations are small
allows the corresponding angles vary within wide
limits, leading to the amorphization of the sub-
stance. The most abundant functional group on
the surface of the particle is the isolated silanol
group. Silanediol groups are located at structural
defects of the surface, but their concentration is
below 10–15% [42]. Later, based on the princi-
ples underlying the modeling of structures, the
authors of [43–45] developed models of the inter-
faces between PNSS particles and polysiloxane
polymers, models that made it possible, in par-
ticular, to understand why the polymer becomes
stiffer upon being filled with PNSS.
a
b
c
Fig. 5. Cluster models of nanosized silica: (a) a frag-
ment of an Aerosil particle comprised of 48
SOT (Si48), (b) siloxane cycle of silica gel
composed of 17 SOT (Si17sg), and (c) polymer
chain of aerogel composed of 12SOT (Si12ag)
Silica gel (SCG). Silica gel is normally pre-
pared in aqueous solutions of silicates of alkali
metals in the presence of an acid [33]. The hy-
E.F. Sheka
_____________________________________________________________________________________________
382 ХФТП 2010. Т. 1. № 4
drolysis of a metal silicate in an aqueous me-
dium produces SOT chains of varying length,
such that each silicon atom is bonded to two hy-
droxyl groups (Fig. 5b). At a high concentration,
chains close to form cycles composed of differ-
ent numbers of silicon atoms. Brought in con-
tact, such cycles form a silica gel pore in the
form of a deflated football with faces of differ-
ent sizes.
Aerogel. The industrial technology for manu-
facturing this product is the hydrolysis of tetra-
ethylorthosilicate catalyzed by an acid or alkali
[46]. The hydrolysis is accompanied by the for-
mation of a silicate polymer in which each atom
is bonded to a hydroxyl group (Fig. 5c). Inter-
twining and bonding to each other, such chains
form a gel.
As can be seen in Fig. 5, distinctions in sili-
con–oxygen structures give rise to the diversity in
the structure of hydroxyl covering of these prod-
ucts, a feature that manifests itself through vibra-
tional spectra recorded by means of inelastic neu-
tron scattering [30]. NSS models presented in
Fig. 5 allow for examining the interaction of a C60
molecule with PNSS modeled by a Si48 cluster
(Fig. 5a) and with SCG modeled by one or two
Si17sg linear cycles. The main focus is therewith
on the possibility of formation of fullerosil and
fullerosilica gel.
FULLEROSIL
Given that the hydroxyl covering of the clus-
ter is heterogeneous, let us examine how a
fullerene molecule is adsorbed at two areas of its
surface with different compositions of hydroxyl
groups. In the first case, the molecule position is
characterized by the shortest distance, Cf –Osiln,
between one of its atoms and the oxygen atom of
a silanol group. In the second case, the initial
distance from Cf to the oxygen atom of a si-
lanediol group, Osild, was determined. The at-
tacking carbon atom was selected among those
characterized by the highest atomic chemical
susceptibility NDA [32]. It turns out that the pa-
rameters of the equilibrium structures of the
complex obtained by full optimization of the
initial structures depend on the initial distances
Cf–Osiln and Cf–Osild. At Cf–Osiln
≤
1.2 Å and
Cf–Osild
≤ 1.6 Å, the fullerene molecule is
bonded to the particle surface in the configura-
tions displayed in Fig. 6. At larger initial dis-
tances, it is not bonded to the particle surface.
a
b
Fig. 6. Equilibrium configurations of the Si48–C60
complex, with the fullerene molecule located
near (a) silanol and (b) silanediol groups [32].
UBS HF AM1 singlet state
As seen in Fig. 6, in both cases the binding of
the C60 molecule to the surface occurs via the for-
mation of Si–Cf bond. The carbon atom substitutes
previously bound hydroxyl that after releasing is
coupled to another carbon atom that is a partner by
a short bond to the first one. The final configura-
tion shown in Fig. 6b differs from that shown in
Fig. 6a in that the silicon atom has a second hy-
droxyl attached, a factor that produces a substantial
effect on the coupling energy of the C60 molecule
to the surface, +10.38 and –6.42 kcal/mol for the
structures shown in Fig. 6a and Fig. 6b, respec-
tively. Since silanediol groups reside predomi-
nantly in defective areas of the particle hydroxyl
covering, their characteristics vary, which is
manifested as a ±1.32 kcal/mol variation in the
energy of coupling the fullerene molecule to the
model cluster.
Thus, for the configuration shown in Fig. 6a,
the attachment a fullerene molecule to a PNSS
particle is an endothermic process and, there-
fore, cannot occur under normal conditions.
Exothermic, as it is, the formation of the second
Compositions for Medicinal Chemistry of Fullerenes
_____________________________________________________________________________________________
ХФТП 2010. Т. 1. № 4 383
configuration (Fig. 6b) is feasible. We believe
that this process is responsible for the adsorption
of small amounts of C60 on PNSS observed in
[40]. According to these experimental data, the
coupling energy of C60 with this substrate is on
the order of a few kcal/mol. The product formed
can be termed fullerosil. The sharp dependence
of whether the addition occurs or not on the ini-
tial distance between the molecule and the parti-
cle surface is suggestive of the existence of a
substantial barrier. The reaction is accompanied
by 0.42 a.u. charge transfer from the particle to
the fullerene. Owing to the presence of C60
molecules, fullerosil exhibits high donor-
acceptor properties with the ionization potential
and electron affinity being 9.58 and 2.35 eV,
respectively.
The obtained characteristics of fullerosil sug-
gest that it may prove to be a highly efficient me-
dicinal agent. A relatively low energy of binding
of the C60 molecule to the surface signifies that it
can be readily detached in a biological medium
from the particle on which it was transported.
Thus, the pharmacological activity of either com-
ponent can reveal itself in the best way. At the
same time, limited by the concentration of si-
lanediol groups, the concentration of C60 mole-
cules is low, a characteristic that may prove fa-
vorable for the possible pharmacological uses of
the complex in light of the specificity of the ac-
tion of medicinal agents administered in ex-
tremely small concentrations [47].
FULLEROSILICA GEL
As discussed above, the surface covering of
nanosized pores in silica gels is largely formed by
silanediols. Since the presence of silanediols was
demonstrated to be the necessary prerequisite for
the formation fullerosil, we assumed that C60
fullerene would readily attach to siloxane rings;
nevertheless, quantum-chemical calculations did
not support this assumption. Fig. 7 shows the ini-
tial and equilibrium configurations of the NSS–
C60 complex imitated by a C60 molecule bonded
to the Si17sg ring. At all reasonable values of the
initial Cf–Osild distances, the C60 molecule was
ejected out of the ring irrespective of whether the
atoms comprising the Si–O–Si chain were al-
lowed to optimize their positions or not. This
means that, if silica gel were composed of indi-
vidual rings, it could have not retained C60
fullerene.
a
b
Fig. 7. Initial (a) and equilibrium (b) configurations of
the Si17sg–C60 complex [32]
However, SCG has a porous structure and
Fig. 8 displays calculation results for an element
of an SCG pore modeled by two Si17sg siloxane
rings. During the optimization of the geometry of
the complex the structures of the siloxane chains
were fixed to reproduce the properties of the ac-
tual SCG silica gel framework while the positions
of the hydroxyl groups were optimized. As can be
seen in Fig. 8a, the fullerene molecule remains
inside the pore. No chemical contacts with the
pore body via Si–C bonds as in the PNSS case are
formed. To within 0.0004 a.u., no charge transfer
occurs between the C60 molecule and the sur-
rounding siloxane rings. Nevertheless, the cou-
pling energy of this complex is quite noticeable
and constitutes -4.13 kcal/mol.
To make the fullerene molecule chemi-
cally interact with one of the siloxane rings
comprising the pore, the rings were made ap-
proach each other, as shown in Fig. 8b.
E.F. Sheka
_____________________________________________________________________________________________
384 ХФТП 2010. Т. 1. № 4
a
b
Fig. 8. Equilibrium configurations of the Si17sg–C60–
Si17sg complex at normal (a) and compresed
(b) configuration of siloxane rings [32]
Under these conditions, the fullerene mole-
cule remains inside one of the rings borrowing a
hydroxyl group and a hydrogen atom from its
silanediol covering. However, the coupling en-
ergy of such a complex has a large positive quan-
tity (41.64 kcal/mol), rendering this configuration
energetically unfavorable. Therefore, when exam-
ining the retention of fullerene molecules in SCG
pore, such in ring configurations should be ex-
cluded from consideration. Thus, the retention of
a C60 molecule in a SCG is a result of the bal-
anced forcing out of the molecule from each of
the rings comprising the pore without the forma-
tion of new chemical bonds. There is good reason
to believe that such a situation will be realized in
an SCG pore of arbitrary shape. Clearly, in some
pores the resultant force acts so as to eject the
molecule while in others, the molecule is re-
tained, with the coupling energy being dependent
on the characteristics of the pore.
Based on these results, a generalized model
of fullerosilica gel is presented in Fig. 9. Let us
look how this construction makes it possible to
explain the main experimental observations for
fullerized SCG.
Fig. 9. A model of fullerosilica gel. The pore in silica
gel was built of three cycles: Si34sg, Si28sg,
and Si17sg
(1) The two-step adsorption isotherms for
LDLP on fullerosilica gel, in contrast to single-
step ones for SCG modified by aromatic mole-
cules, was explained in [36, 38] by the existence
of a 3D adsorption element. This explanation is in
full agreement with our concept that a 3D SCG
pore with a fullerene molecule retained in it can
be considered as a single whole.
(2) The adsorption of LDLP linearly increas-
ing with the fullerene concentration points to the
fullerene molecule being incorporated into the
composition of a complex adsorption element in
the monomeric form. This finding is fully coher-
ent with the suggested general view on fullerene
molecule incorporating inside the SCG pores.
Consequently, the number of elements increases
with the concentration of molecules introduced
being limited only by the number of pores suit-
able for accommodating fullerene.
(3) The LDLP is adsorbed by fullerosilica gel
more effectively than lipoproteins with other struc-
tures can also be explained by the spatial structure
of the adsorption element. As discussed in [33], the
size of linear siloxane cycles only rarely exceeds
20–30 units. As can be seen in Fig. 9, the internal
size of a pore composed of cycles comprised of 17,
28, and 34 SOT is commensurate with the diame-
ter of the fullerene molecule, so that the latter oc-
cupies a significant fraction of the pore, a configu-
ration that prevents high-molecular-weight lipo-
proteins from penetrating into the pore.
Compositions for Medicinal Chemistry of Fullerenes
_____________________________________________________________________________________________
ХФТП 2010. Т. 1. № 4 385
(4) Another feature favorable for the selective
adsorption of LDLP on fullerosilica gel is the do-
nor-acceptor interaction between LDLP and C60.
The observed electron-exchange adsorption of
LDLP [37, 38] is a direct result of this interaction
in which LDLP and C60 act as a donor and an ac-
ceptor, respectively. According to calculations,
the high donor-acceptor characteristics of the C60
molecule experience virtually no change upon its
inclusion into the composition of fullerosilica gel.
For example, the ionization potential and electron
affinity for the adsorption element shown in
Fig. 8a were found to be 9.60 and 2.41 eV, re-
spectively, as compared to 9.86 and 2.66 eV for
the free molecule. It is its high electron affinity
that makes the fullerene molecule so effective in
donor-acceptor interactions with both LDLP and
simple amines.
CONCLUDING REMARKS ON NATURE
OF BIOLOGICAL ACTIVITY
OF FULLERENE
To imagine the character of medicinal effi-
ciency of drugs based on NSS-fullerene composi-
tions let us come back to basics of chemical activ-
ity of fullerenes. It is known that reactive oxygen-
containing species, such as singlet oxygen (1O2)
and superoxide ( _
2
•O ), hydroxy (HO•), and hy-
droperoxy (HOO•) radicals play an important role
in regulating a predominant majority of biological
processes in a living body. Normal or pathologi-
cal conditions of the vital activity of biosystems
are characterized by the corresponding levels of
these species [47]. As other vitally important hu-
man being characteristics, such as temperature,
blood pressure, glucose level in blood, and so
forth, a normal level of the reactive oxygen-
containing species must be kept within a rather
narrow interval. Thus, many pathological condi-
tions are associated with an anomalously high
level of overoxidation of biomolecules [47], spe-
cially, lipids in cellular membranes. At the same
time, it is known that a decrease in the overoxida-
tion level is accompanied by the attenuation of
inflammatory processes. That is why the antioxi-
dant therapy is the most effective if it can support
a normal overoxidation level and thus treat a wide
spectrum of pathological conditions.
To analyze the therapeutic activity of composi-
tions based on NSS-fullerene it is necessary to
compare their characteristics at atomic level with
those related to fullerene-based drugs experienced
in practice. Molecular-colloid solutions containing
hydrated C60 molecules (C60HyFn=C60{H2O}n)
[27, 48–51] seem to be a proper analog. A wide
spectrum of positive therapeutic effects of
C60HyFn administered in small doses, sometimes
comparable with homeopathic ones, led the au-
thors of [50] to assume that "…the C60HyFn show
"wise" and long-term anti-oxidative activity,
maybe due to the universal mechanism of the
level regulation of free radicals (FR) in aqueous
medium that is determined by properties of or-
dered water structures".
The above peculiarities of the antioxidant ac-
tion of C60HyFn are undoubtedly associated with
the C60 molecule being virtually free within the
hydrate complex. Fullerosil and fullerosilica gel
are expected to exhibit a similar antioxidant activ-
ity due to the weak binding between the fullerene
molecules and solid carrier. As to the specific and
"wise" action of C60 fullerene, it is clearly associ-
ated with the radical-type properties of the C60
molecule so that the mechanism of the scaveng-
ing action of the C60 molecule and its hydrate
complex is obvious. Given that each C60 molecule
is capable of trapping tens of radicals, it becomes
self-evident why its antioxidant ability increases
with the concentration of reactive oxygen-
containing species.
What remains unclear is the regulatory func-
tion of the fullerene. In the case of C60HyFn hy-
drates, the feature is connected with a particular
role of the ordered water structure that influences
a recombination of free radicals. As for NSS
compositions, some clues as to how this function
is realized can be obtained by examining the in-
teraction of a fullerene molecule with a PNSS
particle. As can be seen in Fig. 6, the fullerene
molecule tears the hydroxyl group away from the
surface silicon atom while interacting with either
a silanol or a silanediols group. Note, however,
that the energies of these reactions differ signifi-
cantly, even in sign. Thus, while in the former
case, it is energetically more favorable for the
fullerene molecule to return the hydroxy group
back to the surface, in the latter one, it is more
profitable to retain it. Since the electronic charac-
teristics of the radical on the surface (the charges
on the atoms, bond lengths, and valence indices)
are similar in both cases, the distinctions in the
character of the intermolecular interaction are
probably associated with a cooperative effect, the
characteristics of which are determined by the
E.F. Sheka
_____________________________________________________________________________________________
386 ХФТП 2010. Т. 1. № 4
configuration of the atoms surrounding the at-
tacked hydroxyl radical. In our opinion, it does
not seem farfetched to assume that similar coop-
erative effects in a biological medium will ac-
company the absorptive and regulatory functions
of a fullerene molecule as an antioxidant.
REFERENCES
1. Piotrovski L.B. Biological activity of pris-
tine fullerene C60. // Carbon Nanotechnol-
ogy: Recent Developments in Chemistry,
Physics, Materials Science and Device Ap-
plications / Ed. L. Dai. – Amsterdam: El-
sevier, 2006. – P. 235–253.
2. Piotrovski L.B., Kiselev O.I. Fullerenes in
Biology. – St. Petersburg: Rostok, 2006. –
336 p. (in Russian).
3. Da Ros T. Twenty years of promises:
Fullerene in medicinal chemistry / Medici-
nal Chemistry and Pharmacological Poten-
tial of Fullerenes and Carbon Nanotubes /
Eds. F. Cataldo, T. Da Ros. – Berlin:
Springer, 2008. – P. 1–21.
4. Jensen A.W., Wilson S.R., Schuster D.I. Bio-
logical application of fullerenes // Bioorg.
Med. Chem. – 1996. – V. 4. – P. 767–779.
5. Bianco A., Da Ros T., Prato M., To-
niolo C. Fullerene-based amino acids and
peptides // J. Pept. Sci. – 2001. – V. 7. –
P. 208–219.
6. Piotrovski L.B., Kiselev O.I. Fullerenes
and viruses // Fullerenes Nanotubes Car-
bon Nanostr. – 2004. – V. 12, N 1–2. –
P. 397–403.
7. Maeda-Mamiya R., Noiri E., Isobe H. et al.
In vivo gene delivery by cationic
tetraamino fullerene // Proc. Nat. Acad. Sci.
USA. – 2010. – V. 107. – P. 5339–5344.
8. Sheka E.F. Nanoscience of Fullerene: Nano-
chemistry, Nanomedicine, Nanophotonics,
and Nanomagnetism. – Boca Raton: Tay-
lor&Francis, 2010. – 328 p.
9. Krusic P.J., Wasserman P.N., Keiser P.N.
et al. Radical reaction of C60 // Science. –
1991. – V. 254. – P. 1183–1185.
10. Morton J.R., Negri F., Preston K.F. Addi-
tion of free radicals to C60 // Acc. Chem.
Res. – 1998. – V. 31, N 2. – P. 61–69.
11. Wang I.C., Tai L.A., Lee D.D. et al. C60 and
water-soluble fullerene derivatives as anti-
oxidant against radical-initiated lipid per-
oxidation // J. Med. Chem. – 1999. – V. 42,
N 22. – P. 4614–4620.
12. Chabri N., Pressac M., Hadchouel M.
et al. [60] Fullerene is an in vivo powerful
antioxidant with no acute or sub-acute tox-
icity // Nano Lett. – 2005. – V. 5, N 12,
P. 2578–2585.
13. Sheka E.F. Stepwise computational synthe-
sis of fullerene C60 derivatives. 1. Fluori-
nated fullerenes C60F2k. – 2009. –
arXiv:0904.4893v1 [cond-mat.mes-hall]. –
P. 1–33.
14. Sheka E.F. Stepwise computational synthe-
sis of fullerene C60 derivatives 2. Hydrogen-
ated fullerenes from C60 to C60H60. – 2009. –
arXiv:0906.2443 [cond.-mat. mes-hall]. –
P. 1–14.
15. Sheka E.F. Spin flip in oxygen molecule
under photoexcitation of photodynamic
fullerene solutions. – 2010. –
arXiv:1005.2383v1 [cond.-mat. mes-hall].
16. Kasermann F., Kempf C. Photodynamic in-
activation of enveloped viruses by buckmin-
sterfullerene // Antiviral Res. – 1997. –
V. 34, N 1. – P. 65–70.
17. Kasermann F., Kempf C. Buckminster-
fullerene and photodynamic inactivation of
viruses // Rev. Med. Virol. – 1998. – V. 8. –
P. 143–151.
18. Mroz P., Tegos G.P., Gali H. et al. Fullere-
nes as photosensitizers in photodynamic
therapy // Medicinal Chemistry and Pharma-
cological Potential of Fullerenes and Carbon
Nanotubes / Eds. F. Cataldo, T. Da Ros. –
Berlin: Springer, 2008. – P. 79–106.
19. Beck M.T., Mandi G. Solubility of C60 //
Full. Sci. Technol. – 1997. – V. 5. –
P. 291–310.
20. Nath S., Pal H., Palit D.K. et al. Aggrega-
tion of fullerene, C60, in benzonitrile //
J. Phys. Chem. B. – 1998. – V. 102. –
P. 10158–10164.
21. Andrievski G.V., Klochkov V.K., Kar-
yakin E.L., Mchedlov-Petrossyan N.O. Stud-
ies of aqueous colloidal solutions of
fullerene C60 by electron microscopy //
Chem. Phys. Lett. – 1999. – V. 300. –
P. 392–396.
22. Samal S., Geckeler K.E. Unexpected solute
aggregation in water on dilution // J. Chem.
Soc. Chem. Commun. – 2001. – V. 21. –
P. 2224–2225.
Compositions for Medicinal Chemistry of Fullerenes
_____________________________________________________________________________________________
ХФТП 2010. Т. 1. № 4 387
23. Da Ros T., Spalluto G., Prato M. Biological
application of fullerene derivatives: a brief
overview. Croat. Chem. Acta. – 2001. –
V. 74. – P. 743–755.
24. Pat. 5310669 United States, Int C12M1/40
Fullerene coated surfaces and uses thereof /
Richmond R.C., Gibson U.J. – Appl. No.
07/901911, Filed 22.06.1992, Publ.
10.05.1994. – 17 p.
25. Moussa F., Chretien P., Dubois P. et al. The
influence of C60 powders on cultured human
leukocytes // Full. Sci. Technol. – 1995. –
V. 3. – P. 333–342.
26. Lyon D.Y., Adams L.K., Folkner J.C.,
Alvarez P.J.J. Antibacterial activity of
fullerene water suspensions: Effects of
preparation method and particle size //
Environ. Sci. Technol. – 2006. – V. 40. –
P. 4360–4366.
27. Andrievsky G.V., Kosevich M.V.,
Vovk O.M. et al. On the production of an
aqueous colloidal solution of fullerene //
J. Chem. Soc. Chem. Commun. – 1995. –
V. 12. – P. 1281–1282.
28. Andersson T., Nilsson K., Sundahl M. et al.
C60 embedded in g-cyclodextrin; a water
soluble fullerene // J. Chem. Soc. Chem.
Commun. – 1992. – P. 604–605.
29. Yevlampieva N.P., Biryulin Yu.F., Mele-
nevskaya E.Yu. et al. Aggregation of
fullerene C60 in N-methylpyrrolidone //
Colloid Surf. A. – 2002. – V. 209. –
P. 167–171.
30. Sheka E.F., Khavryuchenko V.D., Marki-
chev I.V. Technological polymorphism of
disperse silicas: inelastic neutron scattering
and computer modelling // Russ. Chem.
Rev. – 1995. – V. 64. P. 389–414.
31. Medicinal Chemistry and Clinical Applica-
tion of Silicon Dioxide / Ed. A.A. Chuiko. –
Kiev: Naukova dumka, 2003. – 415 p. (in
Russian).
32. Sheka E.F. Fullerene–silica complexes for
medical chemistry // Russ. J. Phys. Chem. –
2007. – V. 81. – P. 959–966.
33. Iler R.K. The Chemistry of Silica: Solubil-
ity, Polymerization, Colloid and Surface
Properties, and Biochemistry of Silica. –
New York: Interscience, 1979. – 866 p.
34. Silics: a Bioregulating Enterosorbent. Prop-
erties and Clinical Applications / Ed.
A.A. Chuiko. – Kiev: Biofarma, 2003. –
415 p. (in Ukrainian).
35. Chuiko A.A., Pentyuk A.A. Composites of
silica with drugs // Proc. Scientific Session
of the Chemical Department of the National
Academy of Science of Ukraine. – Kharkov:
Osnova, 1998. – P. 35–52. (in Ukrainian).
36. Podosenova N.G., Sedov V.M., An-
dozhskaya Yu.S., Kuznetsov A.S. Adsorption
of low density lipoproteins // Russ. J. Phys.
Chem. – 1997. – V. 71. – P. 1315–1318.
37. Podosenova N.G., Sedov V.M., Kuznet-
sov A.S., Knyazev A.S. New sorbents for
electron-exchange adsorption of low-density
lipoproteins // Russ. J. Phys. Chem. –
1999. – V. 73. – P. 97–100.
38. Podosenova N.G., Sedov V.M., Sharo-
nova L.V., Drichko N.V. Fullerene effects
on the adsorption properties of silica gel
with respect to low-density lipoproteins //
Russ. J. Phys. Chem. – 2001. – V. 75. –
P. 1871–1875.
39. Sedov V.M., Podosenova N.G., Kuznet-
sov A.S. Oxidation of low-density lipopro-
teins in the presence of a fullerene-
containing silica gel // Kinet. Catal. –
2002. – V. 43. – P. 56–60.
40. Davydov V.Y., Sheppard N., Osawa E. An
infrared spectroscopic study of the hydro-
genation and dehydrogenation of the com-
plexes of aromatic compounds and of
fullerene C60 with silica-supported plati-
num // J. Catal. – 2002. – V. 211. P. 42–52.
41. Piwonski I., Zajac J., Jones D.J. et al. Ad-
sorption of [60]fullerene from toluene solu-
tions on MCM-41 silica: a flow microcalo-
rimetric study // Langmuir. – 2000. –
V. 16 – P. 9488–9492.
42. Brei V.V. Hydroxils accommodation on
silica surface // Chemistry, Physics and
Technology of Surface. – 1993. – N 1. –
P. 75–83. (in Russian).
43. Sheka E., Khavryutchenko V., Nikitina E.
From molecule to particle. Quantum-
chemical view applied to fumed silica // J.
Nanopart. Res. – 1999. – V. 1. – P. 71–81.
44. Sheka E.F. Intermolecular interaction and
vibrational spectra at fumed silica parti-
cles/silicone polymer interface //
J. Nanopart. Res. – 2003. – V. 5. –
P. 419–437.
E.F. Sheka
_____________________________________________________________________________________________
388 ХФТП 2010. Т. 1. № 4
45. Nikitina E.A., Khavryutchenko V.D.,
Sheka E.F. et al. Deformation of
poly (dimethylsiloxane) oligomers under
uniaxial tension. Quantum-chemical view //
J. Phys. Chem. A. – 1999. – V. 103. –
P. 11355–11365.
46. Brinker C.J., Keefer K.D., Schaefer D.W.,
Ashley C.S. Sol-gel transition in simple
silicates // J. Non-Cryst. Solids. – 1982. –
V. 48. – P. 47–64.
47. Burlakova E.B. Specific effects of superlow
doses of biologically active substances and
low-level physical factors // Misaha News-
letter. – 2000. – V. 30–31. – P. 2–10.
48. Wang I.C., Tai L.A., Lee D.D. et al. C60 and
water-soluble fullerene derivatives as anti-
oxidants against radical-initiated lipid per-
oxidation // J. Med. Chem. – 1999. –
V. 42. –P. 4614–4620.
49. Andrievsky G., Klochkov V., Bordyuh A.,
Dovbeshko G. Comparative analysis of two
aqueous-colloidal solutions of C60 fullerene
with help of Ft-IR reflectance and UV-Vis
spectroscopy // Chem. Phys. Lett. – 2002. –
V. 364. – P. 8–17.
50. Andrievsky G., Klochkov V., Der-
evyanchenko L. Is C60 fullerene molecule
toxic?! // Fullerenes Nanotubes Carbon
Nanostruct. – 2005. – V. 13. – P. 363–376.
51. Andrievsky G.V., Bruskov V.I., Tykhomy-
rov A.A., Gudkov S.V. Peculiarities of the
antioxidant and radioprotective effects of
hydrated C60 fullerene nanostuctures in vi-
tro and in vivo // Free Rad. Biol. Med. –
2009. – V. 47. – P. 786–793.
Received 25.08.2010, accepted 24.09.2010
Структури фулеренів в медичній хімії
О.Ф. Шека
Російський університет дружби народів
вул. Миклухо-Маклая 6, Москва 117198, Росія, sheka@icp.ac.ru
Стаття присвячена квантово-хімічному розгляду двох аспектів наномедицини фулерену, які
стосуються його оксидативної та антиоксидативної функцій. Перший аспект розглянуто по відно-
шенню до фотодинамічного терапевтичного ефекту розчинів фулерену. Запропоновано новий меха-
нізм цього ефекту. Другий аспект обговорюється на прикладі двох комплексів фулерену з крем-
неземом: фулеросилу та фулеросилікагелю.
Структуры фуллеренов в медицинской химии
Е.Ф. Шека
Российский университет дружбы народов
ул. Миклухо-Маклая 6, Москва 117198, Россия, sheka@icp.ac.ru
Статья посвящена квантово-химическому рассмотрению двух аспектов наномедицины фуллерена,
относящихся к его оксидативной и антиоксидантной функциям. Первый аспект рассмотрен
применительно к фотодинамическому терапевтическому эффекту растворов фуллерена. Предложен
новый механизм этого эффекта. Второй аспект обсуждается на примере двух комплексов фуллерена
с кремнеземом: фуллеросила и фуллеросиликагеля.
|